Cell/Bacteria-Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy

Pan，Hong1; Zheng，Mingbin1,2; Ma，Aiqing1; Liu，Lanlan1; Cai，Lintao1

2021

10.1002/adma.202100241

ADVANCED MATERIALS   影响因子和分区

0935-9648

1521-4095

Numerous clinical trials for cancer precision medicine research are limited due to the drug resistance, side effects, and low efficacy. Unsatisfactory outcomes are often caused by complex physiologic barriers and abnormal immune events in tumors, such as tumor target alterations and immunosuppression. Cell/bacteria-derived materials with unique bioactive properties have emerged as attractive tools for personalized therapy in cancer. Naturally derived bioactive materials, such as cell and bacterial therapeutic agents with native tropism or good biocompatibility, can precisely target tumors and effectively modulate immune microenvironments to inhibit tumors. Here, the recent advances in the development of cell/bacteria-based bioactive materials for immune modulation and precision therapy in cancer are summarized. Cell/bacterial constituents, including cell membranes, bacterial vesicles, and other active substances have inherited their unique targeting properties and antitumor capabilities. Strategies for engineering living cell/bacteria to overcome complex biological barriers and immunosuppression to promote antitumor efficacy are also summarized. Moreover, past and ongoing trials involving personalized bioactive materials and promising agents such as cell/bacteria-based micro/nano-biorobotics are further discussed, which may become another powerful tool for treatment in the near future.

cell/bacteria bioactive materials immunomodulation living drug micro/nano-biorobotics precise therapy targeting delivery

SCI ; EI

英语

其他

WOS:000661032300001

20212410503608

Biocompatibility ; Cells ; Clinical research ; Cytology ; Diseases ; Modulation ; Personalized medicine ; Tumors

Bioengineering and Biology:461

MATERIALS SCIENCE

2-s2.0-85107802686

Scopus

1.Guangdong Key Laboratory of Nanomedicine,CAS-HK Joint Lab for Biomaterials,Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations,Shenzhen Institutes of Advanced Technology (SIAT),Chinese Academy of Sciences,Shenzhen,518055,China
2.National Clinical Research Center for Infectious Disease,Shenzhen Third People's Hospital,The Second Affiliated Hospital,Southern University of Science and Technology,Shenzhen,518112,China

Pan，Hong,Zheng，Mingbin,Ma，Aiqing,et al. Cell/Bacteria-Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy[J]. ADVANCED MATERIALS,2021,33.

Pan，Hong,Zheng，Mingbin,Ma，Aiqing,Liu，Lanlan,&Cai，Lintao.(2021).Cell/Bacteria-Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy.ADVANCED MATERIALS,33.

Pan，Hong,et al."Cell/Bacteria-Based Bioactive Materials for Cancer Immune Modulation and Precision Therapy".ADVANCED MATERIALS 33(2021).